<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(4)</volume><submitter>Masa JF</submitter><pubmed_abstract>&lt;h4>Study objectives&lt;/h4>Pulmonary hypertension (PH) is prevalent in obesity hypoventilation syndrome (OHS). However, there is a paucity of data assessing pathogenic factors associated with PH. Our objective is to assess risk factors that may be involved in the pathogenesis of PH in untreated OHS.&lt;h4>Methods&lt;/h4>In a post hoc analysis of the Pickwick trial, we performed a bivariate analysis of baseline characteristics between patients with and without PH. Variables with a &lt;i>P&lt;/i> value ≤ .10 were defined as potential risk factors and were grouped by theoretical pathogenic mechanisms in several adjusted models. Similar analysis was carried out for the 2 OHS phenotypes, with and without severe concomitant obstructive sleep apnea.&lt;h4>Results&lt;/h4>Of 246 patients with OHS, 122 (50%) had echoca</pubmed_abstract><journal>Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine</journal><pagination>983-992</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8974388</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Risk factors associated with pulmonary hypertension in obesity hypoventilation syndrome.</pubmed_title><pmcid>PMC8974388</pmcid><pubmed_authors>Marti S</pubmed_authors><pubmed_authors>Javaheri S</pubmed_authors><pubmed_authors>Caballero-Eraso C</pubmed_authors><pubmed_authors>Benitez ID</pubmed_authors><pubmed_authors>Mogollon MV</pubmed_authors><pubmed_authors>Barbe F</pubmed_authors><pubmed_authors>Mokhlesi B</pubmed_authors><pubmed_authors>Romero A</pubmed_authors><pubmed_authors>Gonzalez M</pubmed_authors><pubmed_authors>Lopez-Martin S</pubmed_authors><pubmed_authors>Barca J</pubmed_authors><pubmed_authors>de Terreros FJG</pubmed_authors><pubmed_authors>Ordax-Carbajo E</pubmed_authors><pubmed_authors>Troncoso MF</pubmed_authors><pubmed_authors>Sanchez-Quiroga MA</pubmed_authors><pubmed_authors>Egea C</pubmed_authors><pubmed_authors>Marin JM</pubmed_authors><pubmed_authors>Spanish Sleep Network</pubmed_authors><pubmed_authors>Masa JF</pubmed_authors><pubmed_authors>Gallego R</pubmed_authors><pubmed_authors>Chiner E</pubmed_authors><pubmed_authors>Corral J</pubmed_authors><pubmed_authors>Diaz-Cambriles T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risk factors associated with pulmonary hypertension in obesity hypoventilation syndrome.</name><description>&lt;h4>Study objectives&lt;/h4>Pulmonary hypertension (PH) is prevalent in obesity hypoventilation syndrome (OHS). However, there is a paucity of data assessing pathogenic factors associated with PH. Our objective is to assess risk factors that may be involved in the pathogenesis of PH in untreated OHS.&lt;h4>Methods&lt;/h4>In a post hoc analysis of the Pickwick trial, we performed a bivariate analysis of baseline characteristics between patients with and without PH. Variables with a &lt;i>P&lt;/i> value ≤ .10 were defined as potential risk factors and were grouped by theoretical pathogenic mechanisms in several adjusted models. Similar analysis was carried out for the 2 OHS phenotypes, with and without severe concomitant obstructive sleep apnea.&lt;h4>Results&lt;/h4>Of 246 patients with OHS, 122 (50%) had echoca</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-06-13T06:18:54.713Z</modification><creation>2025-04-06T11:14:19.55Z</creation></dates><accession>S-EPMC8974388</accession><cross_references><pubmed>34755598</pubmed><doi>10.5664/jcsm.9760</doi></cross_references></HashMap>